AIG
66
4
ABT
45
-3
AAP
27
3
BEN
41
-9
EA
47
-3
TJX
58
-3
MS
70
-2
XEL
60
-2
KIM
51
4
JBHT
28
-14
HSIC
53
2
MNST
59
2
PSA
48
2
FMC
31
-3
RSG
67
2
MHK
55
10
HAL
50
4
CINF
58
4
GME
75
-14
CHK
39
19
AIG
66
4
ABT
45
-3
AAP
27
3
BEN
41
-9
EA
47
-3
TJX
58
-3
MS
70
-2
XEL
60
-2
KIM
51
4
JBHT
28
-14
HSIC
53
2
MNST
59
2
PSA
48
2
FMC
31
-3
RSG
67
2
MHK
55
10
HAL
50
4
CINF
58
4
GME
75
-14
CHK
39
19
Financhill
Back

Petros Pharmaceuticals 10K Form

Sell
9

PTPI
Petros Pharmaceuticals

Last Price:
0.58
Seasonality Move:
-13.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PTPI News And Ratings

See the #1 stock for the next 7 days that we like better than PTPI

PTPI Financial Statistics

Sales & Book Value

Annual Sales: $5.82M
Cash Flow: $-2.26M
Price / Cash Flow: 0
Annual Sales: $4.04
Price / Book: 0.33

Profitability

EPS (TTM): -6.34000
Net Income (TTM): $-8.16M
Gross Margin: $4.19M
Return on Equity: -63.15%
Return on Assets: -24.82%

Petros Pharmaceuticals Earnings Forecast

Key Petros Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 5 years for PTPI is 71.98%.
  • The Selling, General & Administrative Expenses for PTPI have been equal to 159.07% of Gross Profit Margin.
  • The Research & Development expenses have been 41.38% of Revenue.
  • The Interest Expense is -6.57% of Operating Income.
  • The Net Earning history of PTPI is -140.20% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Petros Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PTPI
CUSIP: 71678J
Website: petrospharma.com

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 1.89
Quick Ratio: 1.44

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PTPI Technical Analysis vs Fundamental Analysis

Sell
9
Petros Pharmaceuticals (PTPI) is a Sell

Is Petros Pharmaceuticals a Buy or a Sell?